SEC Form 5 · accession 0001570523-18-000012
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 2:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 1, 2016 | P | 8,750 | $0.166 | A | 20,800,359 | D | |
| Common stock | Mar 1, 2016 | P | 5,000 | $0.166 | A | 20,800,359 | D | |
| Common stock | Mar 1, 2016 | P | 1,000 | $0.1654 | A | 20,800,359 | D | |
| Common stock | Mar 4, 2016 | P | 1,250 | $0.1616 | A | 20,800,359 | D | |
| Common stock | Mar 4, 2016 | P | 1,750 | $0.163 | A | 20,800,359 | D | |
| Common stock | Mar 4, 2016 | P | 15,000 | $0.163 | A | 20,800,359 | D | |
| Common stock | Mar 4, 2016 | P | 2,000 | $0.163 | A | 20,800,359 | D | |
| Common stock | Mar 7, 2016 | P | 1,000 | $0.1595 | A | 20,800,359 | D | |
| Common stock | Mar 9, 2016 | P | 20,000 | $0.163 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 1,000 | $0.163 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 6,000 | $0.165 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 500 | $0.1648 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 500 | $0.1669 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 2,000 | $0.163 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 5,000 | $0.1623 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 1,200 | $0.163 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 500 | $0.167 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 5,100 | $0.167 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 1,030 | $0.168 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 13,870 | $0.172 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 1,000 | $0.1716 | A | 20,800,359 | D | |
| Common stock | Mar 11, 2016 | P | 15,000 | $0.175 | A | 20,800,359 | D | |
| Common stock | Mar 14, 2016 | P | 3,000 | $0.175 | A | 20,800,359 | D | |
| Common stock | Mar 15, 2016 | P | 1,200 | $0.1745 | A | 20,800,359 | D | |
| Common stock | Mar 15, 2016 | P | 5,000 | $0.17 | A | 20,800,359 | D | |
| Common stock | Mar 15, 2016 | P | 1,250 | $0.171 | A | 20,800,359 | D | |
| Common stock | Mar 15, 2016 | P | 3,750 | $0.1725 | A | 20,800,359 | D | |
| Common stock | Mar 15, 2016 | P | 1,000 | $0.1862 | A | 20,800,359 | D | |
| Common stock | Mar 15, 2016 | P | 5,000 | $0.199 | A | 20,800,359 | D | |
| Common stock | Mar 15, 2016 | P | 5,000 | $0.199 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 8 of 16 submissions.